211 related articles for article (PubMed ID: 15059895)
1. Epigenetic profiling in chronic lymphocytic leukemia reveals novel methylation targets.
Rush LJ; Raval A; Funchain P; Johnson AJ; Smith L; Lucas DM; Bembea M; Liu TH; Heerema NA; Rassenti L; Liyanarachchi S; Davuluri R; Byrd JC; Plass C
Cancer Res; 2004 Apr; 64(7):2424-33. PubMed ID: 15059895
[TBL] [Abstract][Full Text] [Related]
2. CpG island methylation and expression of the secreted frizzled-related protein gene family in chronic lymphocytic leukemia.
Liu TH; Raval A; Chen SS; Matkovic JJ; Byrd JC; Plass C
Cancer Res; 2006 Jan; 66(2):653-8. PubMed ID: 16423993
[TBL] [Abstract][Full Text] [Related]
3. Epigenetic silencing of tumor suppressor long non-coding RNA BM742401 in chronic lymphocytic leukemia.
Wang LQ; Wong KY; Li ZH; Chim CS
Oncotarget; 2016 Dec; 7(50):82400-82410. PubMed ID: 27689399
[TBL] [Abstract][Full Text] [Related]
4. Genome-wide DNA methylation analysis reveals novel epigenetic changes in chronic lymphocytic leukemia.
Pei L; Choi JH; Liu J; Lee EJ; McCarthy B; Wilson JM; Speir E; Awan F; Tae H; Arthur G; Schnabel JL; Taylor KH; Wang X; Xu D; Ding HF; Munn DH; Caldwell C; Shi H
Epigenetics; 2012 Jun; 7(6):567-78. PubMed ID: 22534504
[TBL] [Abstract][Full Text] [Related]
5. Uncovering the DNA methylome in chronic lymphocytic leukemia.
Cahill N; Rosenquist R
Epigenetics; 2013 Feb; 8(2):138-48. PubMed ID: 23321535
[TBL] [Abstract][Full Text] [Related]
6. Frequent epigenetic inactivation of the SLIT2 gene in chronic and acute lymphocytic leukemia.
Dunwell TL; Dickinson RE; Stankovic T; Dallol A; Weston V; Austen B; Catchpoole D; Maher ER; Latif F
Epigenetics; 2009 May; 4(4):265-9. PubMed ID: 19550140
[TBL] [Abstract][Full Text] [Related]
7. Methylation and silencing of protein tyrosine phosphatase receptor type O in chronic lymphocytic leukemia.
Motiwala T; Majumder S; Kutay H; Smith DS; Neuberg DS; Lucas DM; Byrd JC; Grever M; Jacob ST
Clin Cancer Res; 2007 Jun; 13(11):3174-81. PubMed ID: 17545520
[TBL] [Abstract][Full Text] [Related]
8. Assessment of Promoter Methylation Identifies PTCH as a Putative Tumor-suppressor Gene in Human CLL.
Schmidt-Wolf IG; Plass C; Byrd JC; Frevel K; Pietsch T; Waha A
Anticancer Res; 2016 Sep; 36(9):4515-9. PubMed ID: 27630290
[TBL] [Abstract][Full Text] [Related]
9. 450K-array analysis of chronic lymphocytic leukemia cells reveals global DNA methylation to be relatively stable over time and similar in resting and proliferative compartments.
Cahill N; Bergh AC; Kanduri M; Göransson-Kultima H; Mansouri L; Isaksson A; Ryan F; Smedby KE; Juliusson G; Sundström C; Rosén A; Rosenquist R
Leukemia; 2013 Jan; 27(1):150-8. PubMed ID: 22922567
[TBL] [Abstract][Full Text] [Related]
10. Global DNA methylation profiling reveals new insights into epigenetically deregulated protein coding and long noncoding RNAs in CLL.
Subhash S; Andersson PO; Kosalai ST; Kanduri C; Kanduri M
Clin Epigenetics; 2016; 8():106. PubMed ID: 27777635
[TBL] [Abstract][Full Text] [Related]
11. Expression analysis of the epigenetic methyltransferases and methyl-CpG binding protein families in the normal B-cell and B-cell chronic lymphocytic leukemia (CLL).
Kn H; Bassal S; Tikellis C; El-Osta A
Cancer Biol Ther; 2004 Oct; 3(10):989-94. PubMed ID: 15467427
[TBL] [Abstract][Full Text] [Related]
12. A NotI-EcoRV promoter library for studies of genetic and epigenetic alterations in mouse models of human malignancies.
Yu L; Liu C; Bennett K; Wu YZ; Dai Z; Vandeusen J; Opavsky R; Raval A; Trikha P; Rodriguez B; Becknell B; Mao C; Lee S; Davuluri RV; Leone G; Van den Veyver IB; Caligiuri MA; Plass C
Genomics; 2004 Oct; 84(4):647-60. PubMed ID: 15475242
[TBL] [Abstract][Full Text] [Related]
13. Differential genome-wide array-based methylation profiles in prognostic subsets of chronic lymphocytic leukemia.
Kanduri M; Cahill N; Göransson H; Enström C; Ryan F; Isaksson A; Rosenquist R
Blood; 2010 Jan; 115(2):296-305. PubMed ID: 19897574
[TBL] [Abstract][Full Text] [Related]
14. TWIST2 demonstrates differential methylation in immunoglobulin variable heavy chain mutated and unmutated chronic lymphocytic leukemia.
Raval A; Lucas DM; Matkovic JJ; Bennett KL; Liyanarachchi S; Young DC; Rassenti L; Kipps TJ; Grever MR; Byrd JC; Plass C
J Clin Oncol; 2005 Jun; 23(17):3877-85. PubMed ID: 15809452
[TBL] [Abstract][Full Text] [Related]
15. Mantle cell lymphoma displays a homogenous methylation profile: a comparative analysis with chronic lymphocytic leukemia.
Halldórsdóttir AM; Kanduri M; Marincevic M; Mansouri L; Isaksson A; Göransson H; Axelsson T; Agarwal P; Jernberg-Wiklund H; Stamatopoulos K; Sander B; Ehrencrona H; Rosenquist R
Am J Hematol; 2012 Apr; 87(4):361-7. PubMed ID: 22374828
[TBL] [Abstract][Full Text] [Related]
16. Epigenetic inactivation of miR-9 family microRNAs in chronic lymphocytic leukemia--implications on constitutive activation of NFκB pathway.
Wang LQ; Kwong YL; Kho CS; Wong KF; Wong KY; Ferracin M; Calin GA; Chim CS
Mol Cancer; 2013 Dec; 12():173. PubMed ID: 24373626
[TBL] [Abstract][Full Text] [Related]
17. Large-scale analysis of DNA methylation in chronic lymphocytic leukemia.
Rahmatpanah FB; Carstens S; Hooshmand SI; Welsh EC; Sjahputera O; Taylor KH; Bennett LB; Shi H; Davis JW; Arthur GL; Shanafelt TD; Kay NE; Wooldridge JE; Caldwell CW
Epigenomics; 2009 Oct; 1(1):39-61. PubMed ID: 20495622
[TBL] [Abstract][Full Text] [Related]
18. Predicting aberrant CpG island methylation.
Feltus FA; Lee EK; Costello JF; Plass C; Vertino PM
Proc Natl Acad Sci U S A; 2003 Oct; 100(21):12253-8. PubMed ID: 14519846
[TBL] [Abstract][Full Text] [Related]
19. Quantitative DNA methylation analysis identifies a single CpG dinucleotide important for ZAP-70 expression and predictive of prognosis in chronic lymphocytic leukemia.
Claus R; Lucas DM; Stilgenbauer S; Ruppert AS; Yu L; Zucknick M; Mertens D; Bühler A; Oakes CC; Larson RA; Kay NE; Jelinek DF; Kipps TJ; Rassenti LZ; Gribben JG; Döhner H; Heerema NA; Marcucci G; Plass C; Byrd JC
J Clin Oncol; 2012 Jul; 30(20):2483-91. PubMed ID: 22564988
[TBL] [Abstract][Full Text] [Related]
20. Aberrant methylation and silencing of ARHI, an imprinted tumor suppressor gene in which the function is lost in breast cancers.
Yuan J; Luo RZ; Fujii S; Wang L; Hu W; Andreeff M; Pan Y; Kadota M; Oshimura M; Sahin AA; Issa JP; Bast RC; Yu Y
Cancer Res; 2003 Jul; 63(14):4174-80. PubMed ID: 12874023
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]